Eye Surgery Articles & Analysis: Older
16 news found
Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that clinical data from multiple internal and partnered programs were presented at the recent 2022 Annual Meeting of the American Academy of Ophthalmology (AAO), the world's largest association of eye ...
Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer, will present a corporate overview at the Eyecelerator conference on September 29, 2022, as part of the Annual ...
Jeremy Richmon, MD is leading a new clinical trial sponsored by Alume, the Center for Clinical Research Operations' (CCRO) first clinical trial with Head and Neck Surgery. The trial involves using a tracer to help identify nerves intraoperatively. ...
Senstech sensors can be found in a variety of applications in the medical field, such as infusion or insulin pumps, in cardiotocography or in devices for eye surgery. Other important areas of application are textile machinery, mechanical engineering, the watch industry, industrial pressure measurement technology, and applications for cars. ...
We look forward to attending the DOC, which gathers world renowned experts who will present innovations and further developments, and discuss the gold standards of eye surgery. Find out more about the DOC here: https://bit.ly/3GoS9pu ...
The final study results demonstrated that canaloplasty and trabeculotomy performed as an implant-free minimally invasive glaucoma surgery (MIGS) using the OMNI® Surgical System in conjunction with cataract surgery significantly reduced unmedicated mean diurnal intraocular pressure (IOP), medication use and daily fluctuations in IOP in patients with open-angle ...
Dry Eye Syndrome is a chronic disease that affects the productivity and quality of life of 1.52 billion people worldwide [1]. ...
Traditionally, early intervention in glaucoma has been limited primarily to prescription eye drops, with surgery reserved for more severe cases. However, prescription medications are only effective if they are taken as prescribed, and compliance can be a major issue. ...
At Salve Medica, Versius is being used in urology, with plans to expand into general surgery and gynaecology as part of a multispecialty robotics programme. ...
Although the field is relatively young, there are increasingly great examples of VR having a positive effect on patients’ lives and physicians’ work, such as eye surgery simulators to reduce training costs and elevating the teaching and learning experience, speeding up the recovery process and enhancing the therapeutic experiences [2]. ...
In a non-randomized clinical trial of 389 adult and pediatric patients who had the CUSTOMFLEX® ARTIFICIALIRIS implanted in one or both eyes for the treatment of congenital aniridia or other iris defects (Sponsor Clinical Research Consultants, Inc.; Cincinnati, OH), 72% of eyes reported no or mild glare during the day or at night. ...
Ivantis, Inc., developer of the novel Hydrus® Microstent, a minimally invasive glaucoma surgery (MIGS) device designed to lower eye pressure for open-angle glaucoma patients, announced today the first-ever, four-year follow-up data for a MIGS device in an FDA pivotal trial. ...
SPECTRUM is a post market patient registry for the Hydrus® Microstent, a microinvasive glaucoma surgery (MIGS) device to treat patients with open-angle glaucoma in conjunction with cataract surgery or as a stand-alone procedure outside the United States. ...
With XVS, surgeons can see and navigate inside a patient’s body through skin and tissue, which may lead to easier, faster and safer surgeries. The XVS system comprises a transparent near-eye-display headset and has all elements of traditional navigation systems. ...
New members of the medical advisory board include Richard Lindstrom, M.D., founding member and attending surgeon at Minnesota Eye Consultants; and Kuldev Singh, M.D., Professor of Ophthalmology and Director of the Glaucoma Service at Stanford University, who serves on the FDA Advisory Committee for Ophthalmic Devices. ...
Health authorities reported that a tainted dye and injection used during eye surgeries caused 33 cases of rare fungal eye infections. The products were made by the same Florida pharmacy, Franck’s Compounding Lab, that produced the supplements responsible for killing 21 elite polo horses in 2009. All patients with the infections had ...